{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:53:14Z","timestamp":1771476794505,"version":"3.50.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Differences in medical treatment between women and men are common and involve out-of-hospital emergency care, the intensity of pain treatment, and the use of antifibrinolytic treatment in emergency trauma patients. If woman and man receive different antifibrinolytic treatment in highly-standardized major transplant surgery is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective cohort study on patients who underwent liver transplantation at Heidelberg University Hospital, Heidelberg, Germany between 2004 and 2017. Logistic regression analyses were performed to determine if sex is associated with the administration of TXA during liver transplantation. Secondary endpoints included venous thrombotic complications, graft failure, mortality, myocardial infarction, hepatic artery thrombosis, and stroke within the first 30\u2009days after liver transplant as well as length of hospital stay and length of intensive care unit stay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of 779 patients who underwent liver transplantation, 262 patients received TXA. Female sex was not associated with intraoperative administration of TXA [adjusted OR: 0.929 (95% CI 0.654; 1.320), <jats:italic>p<\/jats:italic>\u2009=\u20090.681]. The secondary endpoints graft failure (13.2% vs. 8.4%, women vs. men, <jats:italic>p<\/jats:italic>\u2009=\u20090.039), pulmonary embolism (3.4% vs. 0.9%, women vs. men, <jats:italic>p<\/jats:italic>\u2009=\u20090.012), stroke (1.7% vs. 0.4%, women vs. men, <jats:italic>p<\/jats:italic>\u2009=\u20090.049), and deep vein thrombosis (0.8% vs. 0%, women vs. men, <jats:italic>p<\/jats:italic>\u2009=\u20090.031) within 30\u2009days after liver transplantation were more frequent in women. Mortality, myocardial infarction, and other secondary endpoints did not differ between groups. However, in women, the use of TXA was associated with a lower rate in thromboembolic complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our data indicate that different from other scenarios with massive bleeding complications the administration of TXA during liver transplantation is not associated with sex. However, sex is associated with the risk for complications, and in woman TXA might have a preventive effect on the rate of thromboembolic complications. Reasons underlying the observed sex bias rate remain uncertain.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1452733","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T04:33:55Z","timestamp":1727066035000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient sex and use of tranexamic acid in liver transplantation"],"prefix":"10.3389","volume":"11","author":[{"given":"Sarah","family":"Dehne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Jackson-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Riede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Feisst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianeb","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph W.","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus A.","family":"Weigand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian O.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Larmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/emermed-2020-210215","article-title":"Sex-related differences in opioid administration in the emergency department: a population-based study","volume":"38","author":"Lau","year":"2021","journal-title":"Emerg Med J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.whi.2018.10.007","article-title":"Gender differences in the quality of EMS care Nationwide for chest pain and out-of-hospital cardiac arrest","volume":"29","author":"Lewis","year":"2019","journal-title":"Womens Health Issues"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/1475-6773.13270","article-title":"The influence of sociodemographic factors on trauma center transport for severely injured older adults","volume":"55","author":"Scheetz","year":"2020","journal-title":"Health Serv Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bja.2022.03.032","article-title":"Use of tranexamic acid in major trauma: a sex-disaggregated analysis of the clinical randomisation of an Antifibrinolytic in significant Haemorrhage (CRASH-2 and CRASH-3) trials and UK trauma registry (trauma and audit research network) data","volume":"129","author":"Nutbeam","year":"2022","journal-title":"Br J Anaesth"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/00000542-199611000-00012","article-title":"Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation","volume":"85","author":"Boylan","year":"1996","journal-title":"Anesthesiology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000539-200007000-00006","article-title":"Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation","volume":"91","author":"Dalmau","year":"2000","journal-title":"Anesth Analg"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL clinical practice guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","year":"2022","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.5603\/AIT.a2015.0011","article-title":"Tranexamic acid: a clinical review","volume":"47","author":"Ng","year":"2015","journal-title":"Anaesthesiol Intensive Ther"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1213\/ane.0000000000006804","article-title":"Tranexamic acid administration during liver transplantation is not associated with lower blood loss or with reduced utilization of red blood cell transfusion","volume":"139","author":"Dehne","year":"2024","journal-title":"Anesth Analg"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/medicina59020219","article-title":"Characteristics and outcomes of liver transplantation recipients after tranexamic acid treatment and platelet transfusion: a retrospective single-Centre experience","volume":"59","author":"Alsabani","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/lt.21705","article-title":"A single-center experience of 500 liver transplants using the modified piggyback technique by Belghiti","volume":"15","author":"Mehrabi","year":"2009","journal-title":"Liver Transpl"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","article-title":"Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1055\/s-0040-1718924","article-title":"Fibrinolysis in patients with liver disease","volume":"47","author":"von Meijenfeldt","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4240\/wjgs.v7.i6.86","article-title":"Intraoperative blood loss in orthotopic liver transplantation: the predictive factors","volume":"7","author":"Pandey","year":"2015","journal-title":"World J Gastrointest Surg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jhep.2014.11.023","article-title":"Outcomes in liver transplantation: does sex matter?","volume":"62","author":"Sarkar","year":"2015","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/467976","article-title":"The effect of race, sex, and insurance status on time-to-listing decisions for liver transplantation","volume":"2010","author":"Bryce","year":"2010","journal-title":"J Transplant"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.4254\/wjh.v7.i3.460","article-title":"Gender-based disparities in access to and outcomes of liver transplantation","volume":"7","author":"Oloruntoba","year":"2015","journal-title":"World J Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1097\/tp.0000000000002196","article-title":"Reduced access to liver transplantation in women: role of height, MELD exception scores, and renal function underestimation","volume":"102","author":"Allen","year":"2018","journal-title":"Transplantation"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1111\/j.1600-6143.2010.03326.x","article-title":"Height contributes to the gender difference in wait-list mortality under the MELD-based liver allocation system","volume":"10","author":"Lai","year":"2010","journal-title":"Am J Transplant"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.cgh.2017.02.033","article-title":"Exception points and body size contribute to gender disparity in liver transplantation","volume":"15","author":"Nephew","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41073-016-0007-6","article-title":"Sex and gender equity in research: rationale for the SAGER guidelines and recommended use","volume":"1","author":"Heidari","year":"2016","journal-title":"Res Integr Peer Rev"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/00000542-199708000-00033","article-title":"Fatal pulmonary embolism during liver transplantation","volume":"87","author":"Sopher","year":"1997","journal-title":"Anesthesiology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1213\/00000539-200008000-00009","article-title":"Pulmonary thromboembolism during liver transplantation: possible association with antifibrinolytic drugs and novel treatment options","volume":"91","author":"O'Connor","year":"2000","journal-title":"Anesth Analg"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/lt.20064","article-title":"Intravascular thrombosis and thromboembolism during liver transplantation: antifibrinolytic therapy implicated?","volume":"10","author":"Ramsay","year":"2004","journal-title":"Liver Transpl"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00000539-199708000-00007","article-title":"Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation","volume":"85","author":"Kaspar","year":"1997","journal-title":"Anesth Analg"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1097\/TP.0000000000001682","article-title":"The effectiveness and safety of tranexamic acid in Orthotopic liver transplantation clinical practice: a propensity score matched cohort study","volume":"101","author":"Badenoch","year":"2017","journal-title":"Transplantation"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1600-6143.2006.01591.x","article-title":"Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis","volume":"7","author":"Molenaar","year":"2007","journal-title":"Am J Transplant"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/s0140-6736(11)60278-x","article-title":"The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial","volume":"377","author":"Roberts","year":"2011","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"18434","DOI":"10.1074\/jbc.M401431200","article-title":"Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4","volume":"279","author":"Quinton","year":"2004","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/MBC.0b013e32833c9a9f","article-title":"Plasmin-induced procoagulant effects in the blood coagulation: a crucial role of coagulation factors V and VIII","volume":"21","author":"Ogiwara","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/cc11374","article-title":"Tranexamic acid: less bleeding and less thrombosis?","volume":"16","author":"Godier","year":"2012","journal-title":"Crit Care"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"R117","DOI":"10.1186\/cc6173","article-title":"Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial","volume":"11","author":"Jimenez","year":"2007","journal-title":"Crit Care"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/hep.24390","article-title":"Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men","volume":"54","author":"Lai","year":"2011","journal-title":"Hepatology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/lt.21093","article-title":"Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study","volume":"13","author":"Belli","year":"2007","journal-title":"Liver Transpl"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/lt.21000","article-title":"Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center","volume":"13","author":"Walter","year":"2007","journal-title":"Liver Transpl"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.cgh.2013.09.023","article-title":"Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and Meta-analysis","volume":"12","author":"Wang","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000339344","article-title":"Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience","volume":"86","author":"Heuer","year":"2012","journal-title":"Digestion"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5500\/wjt.v4.i2.81","article-title":"Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease","volume":"4","author":"Khullar","year":"2014","journal-title":"World J Transplant"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/lt.20934","article-title":"Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease","volume":"13","author":"Pfitzmann","year":"2007","journal-title":"Liver Transpl"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/j.1572-0241.2007.01079.x","article-title":"Negative impact of De novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center","volume":"102","author":"Dumortier","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/mbc.0000000000000733","article-title":"Incidence and clinical significance of hyperfibrinolysis during living donor liver transplantation","volume":"29","author":"Kim","year":"2018","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1452733\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T04:33:59Z","timestamp":1727066039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1452733\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":42,"alternative-id":["10.3389\/fmed.2024.1452733"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1452733","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"article-number":"1452733"}}